Japanese Government Procurement

National Hospital Organization - Notice of Procurement (Goods & Services)①Alprolix Intravenous 4000 (4000 International Units, With solution×1 vial/case) 40 cases,②Elrefio subcutaneous injection 76mg (76mg 1.9㎖／1 vial) 20 cases

This procurement is covered by the WTO Agreement on Government Procurement, Japan-EU Economic Partnership Agreement or Japan-UK Comprehensive Economic Partnership Agreement.

Japanese

Publishing date Jul 31, 2025
Type of notice Notice of Procurement (Goods & Services)
Procurement entity National Hospital Organization - Fukui
Classification
0004 Medical & Pharmaceutical Products
Summay of notice ⑴ Official in charge of disbursement of the procuring entity : Yasuhiko Mitsuke, Director, National Hospital Organization Awara National Hospital
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
① Alprolix Intravenous 4000 (4000 International Units, With solution×1 vial/case) 40 cases
② Elrefio subcutaneous injection 76mg (76mg 1.9㎖/1 vial) 20 cases
⑷ Delivery period : From October 1, 2025 to September 30, 2026
⑸ Delivery place : National Hospital Organization Awara National Hospital
⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
B not come under Article 6 of the Regulation concerning Contract for NHO ;
C have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Tokai-Hokuriku Region ;
D prove to have obtained the firstclass license for selling drugs in accordance with the Phamaceutical Affairs Law ;
E prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;
F meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;
⑺ Time-limit for tender : 3 : 00 P.M. September 22, 2025
⑻ Contact point for the notice : Masao Yamamoto, Director, Accounting Division, National Hospital Organization Awara National Hospital, 238-1 Kitagata, Awara-shi, Fukui-ken 910-4272, Japan. TEL 0776-79-1212 ext. 211